glp-1 review article Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic and Meta-Analysis Current Insights, Advantages and Challenges
Description
While most patients adapt within 36 months, some experience diarrhea that continues or emerges after a full year of treatment
Use xylitol gum or lozenges between meals when dryness is noticeable
Seek immediate emergency care for chest pain lasting more than a few minutes, pain radiating to the arm, jaw, neck, or back, or chest discomfort accompanied by shortness of breath, sweating, nausea, or lightheadedness
Nausea A total of 29 trials were evaluated regarding the risk of nausea in patients receiving GLP-1 RAs
M., Park, S
